MedTrace Logo

Validation Study of the Watch HWA09 and Its Softwares ECG-SW1 and PPG-SW1 for the Detection of Atrial Fibrillation

NCT04351386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 283

Last updated 2021-11-16

No results posted yet for this study

Summary

The proposed clinical study aims to validate the diagnostic performance, compared to a reference ECG, of the ECG-SW1 software and the PPG-SW1 software integrated into the HWA09 watch developed by Withings for the automatic identification of atrial fibrillation (AF).

Conditions

Interventions

DEVICE

AF Detection

Recording PPG and single-lead ECG signals with the Withings HWA09 and ECG signal for the reference 12-lead ECG

Sponsors & Collaborators

  • Withings

    lead INDUSTRY

Principal Investigators

  • David CAMPO · Withings

  • Julien NAHUM · Centre Cardiologique du Nord

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-20
Primary Completion
2021-04-07
Completion
2021-04-07

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04351386 on ClinicalTrials.gov